Catalyst Pharmaceuticals, Inc. (CPRX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 59.59M | 44.89M | 32.44M | 71.3M | 60.04M | 70.88M | 72.87M | 64.14M | 31.93M | 55.65M | 45.13M | 30.75M |
| Operating CF Margin % | 39.89% | 29.41% | 21.86% | 48.65% | 42.46% | 49.98% | 56.62% | 52.27% | 32.41% | 50.33% | 43.95% | 30.88% |
| Operating CF Growth % | -0.76% | -36.66% | -55.49% | 11.17% | 88.08% | 27.37% | 61.48% | 108.54% | 164.5% | 38.85% | 9.27% | 17.42% |
| Net Income | 63.73M | 52.7M | 52.78M | 52.11M | 56.74M | 55.94M | 43.88M | 40.79M | 23.27M | 34.84M | -30.76M | 37.76M |
| Depreciation & Amortization | 9.85M | 9.54M | 9.42M | 9.46M | 9.46M | 9.46M | 9.45M | 9.44M | 9.43M | 9.14M | 8.63M | 8.63M |
| Stock-Based Compensation | 0 | 5.66M | 5.67M | 7.6M | 5.85M | 5.17M | 4.42M | 4.41M | 8.25M | 4.25M | 0 | 0 |
| Deferred Taxes | -2.34M | -4.51M | 2.42M | -2.43M | -2.32M | 2.56M | -8.58M | -1.61M | -1.75M | 883K | -13.94M | -3.24M |
| Other Non-Cash Items | 1.38M | -3.33M | 1.77M | 3.62M | -2.63M | -6.69M | -2.77M | 2.46M | 1.36M | -1.13M | 84.81M | 3.3M |
| Working Capital Changes | -13.04M | -15.17M | -39.62M | 946K | -7.05M | 4.45M | 26.47M | 8.65M | -8.65M | 7.65M | -3.61M | -15.7M |
| Change in Receivables | -4.36M | -20.07M | -40.55M | 5.4M | -5.79M | -7.21M | -1.09M | 3.32M | -6.98M | -5.46M | -5.25M | -9.39M |
| Change in Inventory | 2.24M | -9.22M | -9.09M | 455K | -237K | 476K | -2M | 1.94M | -4.31M | -6.61M | 1.72M | -423K |
| Change in Payables | -4.05M | 2.11M | 3.57M | -5.67M | -5.4M | 5.03M | 4.45M | -3.15M | -4.53M | 10.2M | 177K | 1.03M |
| Cash from Investing | -27K | -32K | 0 | -26K | 0 | -88K | -259K | -10K | -199K | -38.32M | -92.82M | 0 |
| Capital Expenditures | -27K | -32K | 0 | -26K | 0 | -88K | -259K | -10K | -199K | -93K | -64K | 0 |
| CapEx % of Revenue | 0.02% | 0.02% | - | 0.02% | - | 0.06% | 0.2% | 0.01% | 0.2% | 0.08% | 0.06% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -38.23M | -79.29M | 0 |
| Cash from Financing | -12.87M | -25.58M | 4.65M | 872K | 3.06M | 4.43M | -5.97M | 1.16M | 141.05M | -665K | -10.13M | -214K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -11.27M | -23.42M | 0 | 2.21M | 0 | 0 | 0 | 0 | 140.7M | 0 | 212K | 617K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -14.57M | -25.3M | 0 | 0 | 0 | 0 | 0 | 0 | -296K | 0 | 0 | 0 |
| Other Financing | -1.6M | -2.16M | 4.65M | -1.34M | 3.06M | 4.43M | -5.97M | 1.16M | 345K | -665K | -10.34M | -831K |
| Net Change in Cash | 46.69M | 19.28M | 37.09M | 72.14M | 63.1M | 75.22M | 66.64M | 65.28M | 172.78M | 16.66M | -57.82M | 30.54M |
| Free Cash Flow | 59.56M | 44.86M | 32.44M | 71.27M | 60.04M | 70.79M | 72.61M | 64.13M | 31.73M | 53.33M | 45.06M | 30.75M |
| FCF Margin % | 39.87% | 29.39% | 21.86% | 48.63% | 42.46% | 49.91% | 56.42% | 52.26% | 32.21% | 48.23% | 43.88% | 30.88% |
| FCF Growth % | -0.8% | -36.63% | -55.33% | 11.15% | 89.25% | 32.74% | 61.13% | 108.51% | 121.11% | 33.07% | 9.11% | 17.55% |
| FCF per Share | 0.47 | 0.35 | 0.26 | 0.56 | 0.47 | 0.56 | 0.58 | 0.51 | 0.26 | 0.47 | 0.42 | 0.27 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.85x | 0.61x | 1.37x | 1.06x | 1.27x | 1.66x | 1.57x | 1.37x | 1.60x | -1.47x | 0.81x |
| Interest Paid | 0 | 0 | 121K | 112K | 103K | 94K | 1.16M | 75K | 65K | 55K | 0 | 0 |
| Taxes Paid | 0 | 0 | 15.89M | 38.6M | 639K | 16.76M | 17.59M | 34.1M | 0 | 8.79M | 0 | 0 |